BCAL Diagnostics (ASX:BDX) Pre-Tax Income : A$-6.40 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. BCAL Diagnostics's pretax income for the six months ended in Dec. 2023 was A$-2.41 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.40 Mil. BCAL Diagnostics's pretax margin was %.

BCAL Diagnostics Pre-Tax Income Historical Data

The historical data trend for BCAL Diagnostics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Pre-Tax Income Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Jun24

Pre-Tax Income

-3.39

-5.06

-6.40

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Pre-Tax Income	Get a 7-Day Free Trial			-2.07	-2.47	-2.59	-2.41	-3.99

Competitive Comparison of BCAL Diagnostics's Pre-Tax Income

For the Diagnostics & Research subindustry, BCAL Diagnostics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's Pre-Tax Income falls into.

BCAL Diagnostics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

BCAL Diagnostics's Pretax Income for the fiscal year that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-9.398	+	3.047	+	-0.042	+	0.051	+	-0.058000000000002
	=	-6.40

BCAL Diagnostics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-4.215	+	1.859	+	-0.053	+	0.002	+	0
	=	-2.41

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-6.40 Mil.

BCAL Diagnostics (ASX:BDX) Pre-Tax Income Explanation

BCAL Diagnostics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2.407	/	0
	=	%

BCAL Diagnostics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.